Skip to main content

HOPA Abstracts

Number-Needed-to-Treat Analyses of Zanubrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia

Abstract #CR13

Patient Perspective: Logistics of Intravenous Iron Administration and Adherence to Therapy

Abstract #CR15

Predictive Factors of Dose Reduction Among Patients Treated With Palbociclib for Advanced or Metastatic Breast Cancer in a Real-World Setting

Abstract #CR17

Real-Life Study: Evaluation of the Safety of PARP Inhibitors in Ovarian Cancer at the Centre Hospitalier de l’Université de Montréal (CHUM)

Abstract #CR18

Pharmacist Interventions Resulting From a Health System Specialty Pharmacy 14-Day Oncology Check-In Protocol

Abstract #LB02

Treatment and Outcomes Associated With Caplacizumab in the Management of Acquired Thrombotic Thrombocytopenic Purpura

Abstract #CR22

Taxane Titration: To Prime or Not to Prime?

Abstract #CR21

Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After High-Dose Cytarabine Consolidation Chemotherapy (the REMEDY Trial)

Abstract #CR19

Survey of PGY-2 Oncology Residency Program Directors to Assess Current Resources and Effects on Burnout

Abstract #CR20

Comparison of the Efficacy of Generic Plerixafor Versus Mozobil as Adjunct Peripheral Blood Stem-Cell Mobilization Agents in Patients With Multiple Myeloma

Abstract #LB01

2
3
4
5
6
7
8

Page 5 of 12
Results 41 - 50 of 119